miércoles, 27 de febrero de 2019

Two courses on data quality to support MCM development for high-consequence pathogens

U.S. Food and Drug Administration - Medical Countermeasures Initiative Update
Photos of course attendees in the Achieving Data Quality and Integrity in Maximum Containment Laboratories Course, which will be held 
April 8-12, 2019. Register to attend this course, or the new course Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens (April 8-10, 2019) by March  7, 2019.
Register by March 7, 2019
Two courses on data quality to support MCM development for high-consequence pathogens

April 8-12, 2019 (Bethesda, MD)
Achieving Data Quality and Integrity in Maximum Containment Laboratories 
This popular course offers a unique opportunity for the regulatory and scientific communities to discuss complex issues in an interactive environment and identify and share best practices for ensuring nonclinical data quality and integrity in BSL-4 facilities. Register

New course focusing on the preparation and execution of research clinical trials to facilitate the approval of medical countermeasures for high-consequence pathogens. Register

Both courses are hosted by FDA's Medical Countermeasures Initiative (MCMi) and the University of Texas Medical Branch at Galveston (UTMB). 

No hay comentarios:

Publicar un comentario